Corteva announces board member resignation

Agricultural firm Corteva , Inc. (NYSE:CTVA), a $44 billion market cap company trading near its 52-week high of $66.24, reported on Wednesday the upcoming departure of Dr. Rebecca Liebert from its Board of Directors. Dr. Liebert will resign effective February 28, 2025, to pursue other opportunities.

This announcement follows her notification to the board on February 13, 2025, of her intention to step down and not seek re-election at the company’s 2025 Annual Meeting of Stockholders.According to InvestingPro analysis, Corteva maintains a FAIR financial health score, with management actively returning value to shareholders through consistent dividend increases and share buybacks.

The company clarified that Dr. Liebert’s decision to resign was not due to any disagreements with the company’s management or board regarding Corteva’s operations, policies, or practices. In response to her departure, Corteva’s board will decrease its number of directors from thirteen to twelve.

Corteva’s management and board have expressed their gratitude to Dr. Liebert for her dedicated service and contributions during her tenure. The company, headquartered in Indianapolis, Indiana, operates within the crop production industry and is known for its focus on agricultural chemicals and seeds. The company has raised its dividend for six consecutive years and achieved a notable 19% price return over the past six months.

In other recent news, Corteva Inc. has been the focus of several significant developments. BofA Securities and Mizuho (NYSE:MFG) analysts have both raised their stock price targets for the company to $73 and $71 respectively, citing potential for growth despite challenges in the agricultural economy. Both firms maintain a positive outlook for Corteva, highlighting its stability and potential for double-digit EBITDA growth amidst the current market conditions.

In financial news, Corteva reported its fourth-quarter EBITDA at $525 million, aligning closely with market expectations. The company’s adjusted earnings per share came in at $0.32, surpassing estimates. Despite foreign exchange headwinds, analysts remain optimistic about Corteva’s prospects, citing volume growth, higher pricing, and lower costs as contributing factors to a projected increase in EBITDA by 2025.

However, EIDP Inc., a company associated with Corteva, announced a significant restatement of its financial statements due to a misclassification of cash flows related to intercompany loan activities. The misclassification, which did not affect Corteva’s consolidated financial statements, will be corrected in EIDP’s upcoming Annual Report.

Finally, despite Corteva reporting fourth-quarter results in line with expectations, its shares experienced a decrease due to weaker-than-expected guidance for 2025. The company expects 2025 revenue between $17.2 billion and $17.6 billion, with earnings per share guidance falling short of consensus estimates. Despite this, Corteva plans to repurchase approximately $1 billion of shares in 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.